(State or Other Jurisdiction of Incorporation) |
(Commission File Number)
|
(IRS Employer Identification No.) |
|
Written communications pursuant to Rule 425 under the Securities Act.
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
|
|
|
|
Pre-commencement communications pursuant to Rule 14d-2b under the Exchange Act.
|
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
|
Title of Class
|
Trading Symbol(s)
|
Exchange Name
|
|
|
|
Item 3.01
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
AVENUE THERAPEUTICS, INC.
|
||
(Registrant)
|
||
Date: March 29, 2024
|
||
By:
|
/s/ David Jin
|
|
David Jin
|
||
Interim Principal Financial Officer and Chief Operating Officer
|
Document And Entity Information |
Mar. 26, 2024 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | Avenue Therapeutics, Inc. |
Document, Type | 8-K |
Document, Period End Date | Mar. 26, 2024 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 001-38114 |
Entity, Tax Identification Number | 47-4113275 |
Entity, Address, Address Line One | 1111 Kane Concourse, Suite 301 |
Entity, Address, City or Town | Bay Harbor Islands |
Entity, Address, State or Province | FL |
Entity, Address, Postal Zip Code | 33154 |
City Area Code | 781 |
Local Phone Number | 652-4500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | ATXI |
Security Exchange Name | NASDAQ |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0001644963 |
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end